CMS Eliminates Metrics in Medicare Advantage Star Ratings, Boosting Insurers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 04 2026
0mins
Source: seekingalpha
- Medicare Advantage Reform: The CMS has finalized a decision to eliminate nearly 11 metrics from the Medicare Advantage Star Ratings system, which is expected to provide health insurers with over $18 billion in funding over the next decade, significantly improving their financial profiles.
- Impact on Star Ratings: This reform is anticipated to enhance the star ratings of Medicare Advantage plans, particularly those achieving four stars or more, which will receive annual bonus payments from the government, thereby strengthening insurers' competitive positions in the market.
- Taxpayer Burden Relief: According to the final CMS regulation, the changes are projected to cost taxpayers about $13 billion, but they will simultaneously provide much-needed funding for health insurers, alleviating pressure as they await decisions on 2027 reimbursement rates.
- Positive Market Reaction: Following this announcement, the market outlook for Medicare Advantage insurers appears optimistic, especially as the proposed reimbursement rates for 2027 are expected to remain relatively flat, allowing insurers to benefit from the influx of new funding.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to fall
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 426.540
Low
330.00
Averages
397.82
High
444.00
Current: 426.540
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Group's AI Investment Drives Earnings Growth
- AI Investment Strategy: UnitedHealth Group plans to invest $3 billion in artificial intelligence from 2026 to 2027, with management stating that for every $1 invested, approximately $2 in value is generated, significantly reducing administrative costs and enhancing productivity, thereby strengthening the long-term investment case.
- Efficiency Gains: The company is utilizing AI tools to automate customer service, summarize clinical records, and process administrative requests, expecting to realize returns on investment within 12 to 18 months, which helps address the high-cost issues in the healthcare sector.
- Software Product Development: About one-third of the AI investment is directed towards software products within Optum Insight, aiming to redesign internal workflows, enhance employee productivity, and optimize operational efficiency.
- Strong Financial Performance: In Q1 2026, UnitedHealth generated $111.7 billion in revenue and adjusted earnings of $7.23 per share, both exceeding Wall Street expectations, while also raising full-year earnings guidance to over $18.25 per share, reflecting improved operational performance.
See More
UnitedHealth Group Invests $3 Billion in AI Strategy
- Strategic Investment: UnitedHealth Group plans to invest $3 billion in AI from 2026 to 2027, with management indicating that for every $1 invested, approximately $2 in value is generated, significantly reducing administrative costs and enhancing productivity.
- Efficiency Gains: The company is leveraging AI tools to automate customer service, summarize clinical records, and detect fraud, expecting to realize returns on its investments within 12 to 18 months while further optimizing internal operational workflows.
- Market Performance: In Q1 2026, UnitedHealth generated $111.7 billion in revenue and adjusted earnings of $7.23 per share, both exceeding Wall Street expectations, with management raising full-year earnings guidance to over $18.25 per share, reflecting improved operational performance.
- Competitive Advantage: By reducing administrative expenses and enhancing customer service, UnitedHealth's AI investments not only address cost issues in healthcare but also have the potential to expand margins across multiple business lines, becoming a significant driver of long-term earnings growth.
See More
Healthcare Sector Rally: Raymond James Picks New Stars
- Healthcare Sector Rally: The healthcare sector surged over 6% in June as investors shifted towards defensive plays, reflecting strong interest in healthcare stocks amid poor performance in tech stocks.
- UnitedHealth Group's Strong Performance: UnitedHealth's stock has risen 28%, with expectations for near-term gains from its earnings report on July 16, driven by moderating medical cost trends and improving insurance margins.
- Dividend Growth and Analyst Ratings: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, with 80% of analysts rating it a buy, although the consensus price target suggests a potential 3% decline over the next year.
- Emerging Opportunities for Janus Living: Janus Living, a newly public company, has seen its stock rise 45% since its IPO, with analysts optimistic about its growth potential in the senior housing market, supporting its future market performance.
See More
Analysis of Schwab U.S. Dividend ETF Investment Strategy
- Clear Investment Strategy: The Schwab U.S. Dividend Equity ETF (SCHD) aims to closely track the Dow Jones U.S. Dividend 100 Index, which screens for companies with higher yields, consistent dividend payments, and strong financial metrics, ensuring investment in 100 high-quality, high-yield dividend stocks.
- Annual Restructuring Optimization: The index undergoes annual screening, recently removing 22 lower-quality stocks and adding 25 new ones, maintaining an average yield of 3.4%, significantly above the S&P 500's 1.1%, while increasing the five-year dividend growth rate to 9.4%.
- Significant Long-term Returns: Since its inception in 2011, the Schwab U.S. Dividend Equity ETF has delivered an annualized total return of 13.3%, demonstrating the strong returns from its concentrated focus on high-yield dividend growth stocks, thus affirming the long-term investment value of dividend growth stocks.
- Diversified Investment Portfolio: By holding the Schwab U.S. Dividend Equity ETF, investors can further diversify their dividend investment portfolios, particularly by adding high-quality dividend stocks in the healthcare sector, such as UnitedHealth Group (UNH), which has consistently paid dividends since 1990 and increased payouts for 16 consecutive years.
See More
Analysis of Schwab U.S. Dividend Equity ETF Investment
- Clear Investment Strategy: The Schwab U.S. Dividend Equity ETF aims to closely track the Dow Jones U.S. Dividend 100 Index, which screens for high-yield, consistently dividend-paying companies, ensuring quality and income potential in its portfolio.
- Strong Performance: Since its inception in 2011, the ETF has delivered an annualized total return of 13.3%, significantly outperforming the S&P 500, demonstrating its robust performance among high-yield dividend growth stocks.
- Diversified Portfolio: By investing in the Schwab ETF, investors gain exposure to a broader range of high-quality dividend stocks, particularly in the healthcare sector, including top holdings like UnitedHealth Group, enhancing portfolio diversification.
- Dividend Growth Potential: The ETF's holdings have an average dividend yield of 3.4% and a five-year annualized dividend growth rate of 9.4%, indicating its potential for providing stable income and long-term capital appreciation.
See More
Guardant Shield Blood Test Gains Coverage from UnitedHealth
- Coverage Expansion: UnitedHealth, the leading U.S. health insurer, announced that effective August 1, Guardant's Shield product will be covered for colorectal cancer screening, significantly enhancing Guardant's market opportunities and sales potential.
- Stock Surge: Following UnitedHealth's announcement, shares of Guardant Health (GH) surged nearly 10% on Wednesday, and if this gain holds, it is expected to reach five-year highs, reflecting optimistic market sentiment towards the company's prospects.
- Analyst Optimism: BTIG raised GH's price target from $150 to $190, implying nearly 27% upside from Tuesday's closing price, and noted that the timing of this coverage is 1-2 years ahead of expectations, potentially prompting other commercial payors to follow suit.
- Retail Investor Sentiment: According to Stocktwits, retail sentiment towards GH remained bullish over the past 24 hours, with the stock gaining approximately 61% year-to-date and more than tripling in value over the past 12 months, significantly outperforming the S&P index.
See More
UnitedHealth Group's AI Investment Drives Earnings Growth
- AI Investment Strategy: UnitedHealth Group plans to invest $3 billion in artificial intelligence from 2026 to 2027, with management stating that for every $1 invested, approximately $2 in value is generated, significantly reducing administrative costs and enhancing productivity, thereby strengthening the long-term investment case.
- Efficiency Gains: The company is utilizing AI tools to automate customer service, summarize clinical records, and process administrative requests, expecting to realize returns on investment within 12 to 18 months, which helps address the high-cost issues in the healthcare sector.
- Software Product Development: About one-third of the AI investment is directed towards software products within Optum Insight, aiming to redesign internal workflows, enhance employee productivity, and optimize operational efficiency.
- Strong Financial Performance: In Q1 2026, UnitedHealth generated $111.7 billion in revenue and adjusted earnings of $7.23 per share, both exceeding Wall Street expectations, while also raising full-year earnings guidance to over $18.25 per share, reflecting improved operational performance.
See More
UnitedHealth Group Invests $3 Billion in AI Strategy
- Strategic Investment: UnitedHealth Group plans to invest $3 billion in AI from 2026 to 2027, with management indicating that for every $1 invested, approximately $2 in value is generated, significantly reducing administrative costs and enhancing productivity.
- Efficiency Gains: The company is leveraging AI tools to automate customer service, summarize clinical records, and detect fraud, expecting to realize returns on its investments within 12 to 18 months while further optimizing internal operational workflows.
- Market Performance: In Q1 2026, UnitedHealth generated $111.7 billion in revenue and adjusted earnings of $7.23 per share, both exceeding Wall Street expectations, with management raising full-year earnings guidance to over $18.25 per share, reflecting improved operational performance.
- Competitive Advantage: By reducing administrative expenses and enhancing customer service, UnitedHealth's AI investments not only address cost issues in healthcare but also have the potential to expand margins across multiple business lines, becoming a significant driver of long-term earnings growth.
See More
Healthcare Sector Rally: Raymond James Picks New Stars
- Healthcare Sector Rally: The healthcare sector surged over 6% in June as investors shifted towards defensive plays, reflecting strong interest in healthcare stocks amid poor performance in tech stocks.
- UnitedHealth Group's Strong Performance: UnitedHealth's stock has risen 28%, with expectations for near-term gains from its earnings report on July 16, driven by moderating medical cost trends and improving insurance margins.
- Dividend Growth and Analyst Ratings: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, with 80% of analysts rating it a buy, although the consensus price target suggests a potential 3% decline over the next year.
- Emerging Opportunities for Janus Living: Janus Living, a newly public company, has seen its stock rise 45% since its IPO, with analysts optimistic about its growth potential in the senior housing market, supporting its future market performance.
See More
Analysis of Schwab U.S. Dividend ETF Investment Strategy
- Clear Investment Strategy: The Schwab U.S. Dividend Equity ETF (SCHD) aims to closely track the Dow Jones U.S. Dividend 100 Index, which screens for companies with higher yields, consistent dividend payments, and strong financial metrics, ensuring investment in 100 high-quality, high-yield dividend stocks.
- Annual Restructuring Optimization: The index undergoes annual screening, recently removing 22 lower-quality stocks and adding 25 new ones, maintaining an average yield of 3.4%, significantly above the S&P 500's 1.1%, while increasing the five-year dividend growth rate to 9.4%.
- Significant Long-term Returns: Since its inception in 2011, the Schwab U.S. Dividend Equity ETF has delivered an annualized total return of 13.3%, demonstrating the strong returns from its concentrated focus on high-yield dividend growth stocks, thus affirming the long-term investment value of dividend growth stocks.
- Diversified Investment Portfolio: By holding the Schwab U.S. Dividend Equity ETF, investors can further diversify their dividend investment portfolios, particularly by adding high-quality dividend stocks in the healthcare sector, such as UnitedHealth Group (UNH), which has consistently paid dividends since 1990 and increased payouts for 16 consecutive years.
See More
Analysis of Schwab U.S. Dividend Equity ETF Investment
- Clear Investment Strategy: The Schwab U.S. Dividend Equity ETF aims to closely track the Dow Jones U.S. Dividend 100 Index, which screens for high-yield, consistently dividend-paying companies, ensuring quality and income potential in its portfolio.
- Strong Performance: Since its inception in 2011, the ETF has delivered an annualized total return of 13.3%, significantly outperforming the S&P 500, demonstrating its robust performance among high-yield dividend growth stocks.
- Diversified Portfolio: By investing in the Schwab ETF, investors gain exposure to a broader range of high-quality dividend stocks, particularly in the healthcare sector, including top holdings like UnitedHealth Group, enhancing portfolio diversification.
- Dividend Growth Potential: The ETF's holdings have an average dividend yield of 3.4% and a five-year annualized dividend growth rate of 9.4%, indicating its potential for providing stable income and long-term capital appreciation.
See More
Guardant Shield Blood Test Gains Coverage from UnitedHealth
- Coverage Expansion: UnitedHealth, the leading U.S. health insurer, announced that effective August 1, Guardant's Shield product will be covered for colorectal cancer screening, significantly enhancing Guardant's market opportunities and sales potential.
- Stock Surge: Following UnitedHealth's announcement, shares of Guardant Health (GH) surged nearly 10% on Wednesday, and if this gain holds, it is expected to reach five-year highs, reflecting optimistic market sentiment towards the company's prospects.
- Analyst Optimism: BTIG raised GH's price target from $150 to $190, implying nearly 27% upside from Tuesday's closing price, and noted that the timing of this coverage is 1-2 years ahead of expectations, potentially prompting other commercial payors to follow suit.
- Retail Investor Sentiment: According to Stocktwits, retail sentiment towards GH remained bullish over the past 24 hours, with the stock gaining approximately 61% year-to-date and more than tripling in value over the past 12 months, significantly outperforming the S&P index.
See More
